Survival with combined modality therapy after intracerebral recurrence of pleuropulmonary blastoma

被引:0
作者
Yusuf, U
Dufour, D
Jenrette, JM
Abboud, MR
Laver, J
Barredo, JC
机构
[1] MED UNIV S CAROLINA,CHILDRENS HOSP,DIV PEDIAT HEMATOL ONCOL,CHARLESTON,SC 29425
[2] MED UNIV S CAROLINA,DEPT RADIAT ONCOL,CHARLESTON,SC 29425
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1998年 / 30卷 / 01期
关键词
pleuropulmonary blastoma; chemotherapy; high-dose cyclophosphamide;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. We present and discuss the successful treatment of pleuropulmonary blastoma metastatic to the brain using a multimodality regimen with surgery, high-dose chemotherapy and radiation therapy. Procedure. A 3-year-old boy referred to our institution with bilateral pulmonary cysts was diagnosed with pleuropulmonary blastoma (PPB). Initial treatment included surgery and multiagent chemotherapy with vincristine, dactinomycin, cyclophosphamide, cisplatin, and doxorubicin. One year after the completion of therapy, his PPB recurred as an intracerebral metastasis, and required further treatment with a multimodality salvage regimen. The child was successfully treated with a subtotal surgical resection, followed by high-dose cyclophosphamide, and radiation therapy. He is now disease-free 24 months later. Results. Intracerebral metastases of PPB have been a uniformly fatal complication of this tumor. Postsurgical chemotherapy and radiation therapy appear to have contributed to the prolonged survival and potential for cure in our patient. Conclusions. The use of this multimodality regimen may be warranted in other patients with recurrent PPB metastatic to the brain. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 17 条
  • [1] BARRETT NR, 1944, BRIT J SURG, V31, P447
  • [2] CALABRIA R, 1993, AM SURGEON, V59, P192
  • [3] COHEN M, 1991, Pediatric Pathology, V11, P737
  • [4] Dehner Louis P., 1995, V18, P214
  • [5] PULMONARY BLASTOMA ASSOCIATED WITH CYSTIC LESIONS IN CHILDREN
    HOLLANDMORITZ, RM
    HEYN, RM
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (02): : 85 - 88
  • [6] Koss M N, 1995, Cancer Treat Res, V72, P349
  • [7] KOSS MN, 1991, CANCER, V67, P2368, DOI 10.1002/1097-0142(19910501)67:9<2368::AID-CNCR2820670926>3.0.CO
  • [8] 2-G
  • [9] MANIVEL JC, 1988, CANCER, V62, P1516, DOI 10.1002/1097-0142(19881015)62:8<1516::AID-CNCR2820620812>3.0.CO
  • [10] 2-3